Protective effect of panaxatriol saponins extracted from Panax notoginseng against MPTP-induced neurotoxicity in vivo

Journal of Ethnopharmacology

Volumn 133, Issue 2, 2011, Pages 448-453

  Luo, Fu Cheng ^a   Wang, Sheng Dong ^a   Qi, Lei ^a   Song, Jun Ying ^a   Lv, Tao ^a   Bai, Jie ^a  

^a KUNMING UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Cyclooxygenase 2; Mitochondria; Panax notoginseng; Panaxatriol saponins; Parkinson's disease; Thioredoxin 1

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; CASPASE 3; CYCLOOXYGENASE 2; NEUROPROTECTIVE AGENT; PANAX NOTOGINSENG EXTRACT; PANAXATRIOL SAPONIN; PROCASPASE 12; PROCASPASE 9; PROTEIN PRECURSOR; SAPONIN; THIOREDOXIN 1; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BEHAVIOR DISORDER; BRAIN MITOCHONDRION; DOPAMINERGIC NERVE CELL; DOWN REGULATION; ENZYME ACTIVATION; IN VIVO STUDY; LOCOMOTION; MALE; MOUSE; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PANAX NOTOGINSENG; PROTEIN EXPRESSION; SUBSTANTIA NIGRA PARS COMPACTA;

ANIMALS; APOPTOSIS; CASPASE 12; CASPASE 3; CASPASE 9; CHINA; CYCLOOXYGENASE 2; DRUGS, CHINESE HERBAL; ENZYME PRECURSORS; ETHNOPHARMACOLOGY; GINSENOSIDES; MALE; MICE; MITOCHONDRIA; MOTOR ACTIVITY; MPTP POISONING; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTOXINS; PANAX NOTOGINSENG; SAPONINS; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

PANAX NOTOGINSENG;

EID: 78651402013     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2010.10.017     Document Type: Article

References (38)

1. K. Aoyama, N. Matsumura, M. Watabe, and T. Nakaki Oxidative stress on EAAC1 is involved in MPTP-induced glutathione depletion and motor dysfunction European Journal of Neuroscience 27 2008 20 30
2. N. Arai, K. Misugi, Y. Goshima, and Y. Misu Evaluation of a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated C57 black mouse model for parkinsonism Brain Research 515 1990 57 63
3. J. Bai, H. Nakamura, I. Hattori, M. Tanito, and J. Yodoi Thioredoxin suppresses 1-methyl-4-phenylpyridinium-induced neurotoxicity in rat PC12 cells Neuroscience Letters 321 2002 81 84
4. J. Bai, H. Nakamura, Y.W. Kwon, I. Hattori, Y. Yamaguchi, Y.C. Kim, N. Kondo, S. Oka, S. Ueda, H. Masutani, and J. Yodoi Critical roles of thioredoxin in nerve growth factor-mediated signal transduction and neurite outgrowth in PC12 cells Journal of Neuroscience 23 2003 503 509
5. J. Bai, H. Nakamura, Y.W. Kwon, M. Tanito, S. Ueda, T. Tanaka, I. Hattori, S. Ban, T. Momoi, Y. Kitao, S. Ogawa, and J. Yodoi Does thioredoxin-1 prevent mitochondria- and endoplasmic reticulum-mediated neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine? Antioxidants and Redox Signaling 9 2007 603 608
6. A. Burke-Gaffney, M.E.J. Callister, and H. Nakamura Thioredoxin: friend or foe in human disease? Trends in Pharmacological Sciences 26 2005 398 404
7. R.K. Chaturvedi, S. Shukla, K. Seth, and A.K. Agrawal Nerve growth factor increases survival of dopaminergic graft, rescue nigral dopaminergic neurons and restores functional deficits in rat model of Parkinson's disease Neuroscience Letters 398 2006 44 49
8. K.C. Das, and C.K. Das Thioredoxin, a singlet oxygen quencher and hydroxyl radical scavenger: redox independent functions Biochemical and Biophysical Research Communications 277 2000 443 447
9. M. Endoh, T. Kunishita, and T. Tabira Thioredoxin from activated macrophages as a trophic factor for central cholinergic neurons in vitro Biochemical and Biophysical Research Communications 192 1993 760 765
10. Z.H. Feng, T.G. Wang, D.D. Li, P. Fung, B.C. Wilson, B. Liu, S.F. Ali, R. Langenbach, and J.S. Hong Cyclooxygenase-2-deficient mice are resistant to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced damage of dopaminergic neurons in the substantia nigra Neuroscience Letters 329 2002 354 358
11. R.M. Friedlander Mechanisms of disease: apoptosis and caspases in neurodegenerative diseases New England Journal of Medicine 348 2003 1365 1375
12. E. Fujita, Y. Kouroku, A. Jimbo, A. Isoai, K. Maruyama, and T. Momoi Caspase-12 processing and fragment translocation into nuclei of tunicamycin-treated cells Cell Death and Differentiation 9 2002 1108 1114
13. D.M. Gash, Z.M. Zhang, A. Ovadia, W.A. Cass, A. Yi, L. Simmerman, D. Russell, D. Martin, P.A. Lapchak, F. Collins, B.J. Hoffer, and G.A. Gerhardt Functional recovery in parkinsonian monkeys treated with GDNF Nature 380 1996 252 255
14. A. Hartmann, S. Hunot, P.P. Michel, M.P. Muriel, S. Vyas, B.A. Faucheux, A. Mouatt-Prigent, H. Turmel, A. Srinivasan, M. Ruberg, G.I. Evan, Y. Agid, and E.C. Hirsch Caspase-3: a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease Proceedings of the National Academy of Sciences of the United States of America 97 2000 2875 2880
15. S. Hunot, M. Vila, P. Teismann, R.J. Davis, E.C. Hirsch, S. Przedborski, P. Rakic, and R.A. Flavell JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease Proceedings of the National Academy of Sciences of the United States of America 101 2004 665 670
16. Y. Itano, Y. Kitamura, and Y. Nomura 1-Methyl-4-phenylpyridinium (MPP(+))-induced cell death in PC12 cells - inhibitory effects of several drugs Neurochemistry International 25 1994 419 424
17. S. Karunakaran, L. Diwakar, U. Saeed, V. Agarwal, S. Ramakrishnan, S. Iyengar, and V. Ravindranath Activation of apoptosis signal regulating kinase 1 (ASK1) and translocation of death-associated protein Daxx, in substantia nigra pars compacta in a mouse model of Parkinson's disease: protection by alpha-lipoic acid The FASEB Journal 21 2007 2226 2236
18. S.J. Kish, C. Morito, and O. Hornykiewicz Glutathione peroxidase activity in Parkinson's disease brain Neuroscience Letters 58 1985 343 346
19. J.B. Koprich, C. Reske-Nielsen, P. Mithal, and O. Isacson Neuroinflammation mediated by IL-1 beta increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease Journal of Neuroinflammation 5 2008
20. O.A. Levy, C. Malagelada, and L.A. Greene Cell death pathways in Parkinson's disease: proximal triggers, distal effectors, and final steps Apoptosis 14 2009 478 500
21. C. Liu, C. Wang, P. Liu, and Q. Feng Analyze on curative effect of PTS in treatment of 116 cases of cerebral infaction Journal of Chengdu University of Traditional Chinese Medicine 30 2007 6 7
22. F.C. Luo, S.D. Wang, K. Li, H. Nakamura, J. Yodoi, and J.E. Bai Panaxatriol saponins extracted from Panax notoginseng induces thioredoxin-1 and prevents 1-methyl-4-phenylpyridinium ion-induced neurotoxicity Journal of Ethnopharmacology 127 2010 419 423
23. M. Matsuda, H. Masutani, H. Nakamura, S. Miyajima, A. Yamauchi, S. Yonehara, A. Uchida, K. Irimajiri, A. Horiuchi, and J. Yodoi Protective activity of adult T-cell leukemia-derived factor (ADF) against tumor necrosis factor-dependent cytotoxicity on U937 cells Journal of Immunology 147 1991 3837 3841
24. M. Mogi, A. Togari, T. Kondo, Y. Mizuno, O. Komure, S. Kuno, H. Ichinose, and T. Nagatsu Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease Neuroscience Letters 270 1999 45 48
25. T. Nagatsu, M. Mogi, H. Ichinose, and A. Togari Changes in cytokines and neurotrophins in Parkinson's disease (Supplement) Journal of Neural Transmission 2000 277 290
26. J. Poirier, D. Dea, A. Baccichet, and C. Thiffault Superoxide dismutase expression in Parkinson's disease Annals of the New York Academy of Sciences 738 1994 116 120
27. M. Saitoh, H. Nishitoh, M. Fujii, K. Takeda, K. Tobiume, Y. Sawada, M. Kawabata, K. Miyazono, and H. Ichijo Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1 The EMBO Journal 17 1998 2596 2606
28. Z. Salehi, and F. Mashayekhi Brain-derived neurotrophic factor concentrations in the cerebrospinal fluid of patients with Parkinson's disease Journal of Clinical Neuroscience 16 2009 90 93
29. Y. Su, and Y. Zhao The effect of PTS on platelet function and thrombosis Chinese Traditional and Herbal Drugs 27 1996 666 669
30. J. Takeuchi, K. Hirota, T. Itoh, R. Shinkura, K. Kitada, J. Yodoi, T. Namba, and K. Fukuda Thioredoxin inhibits tumor necrosis factor- or interleukin-1-induced NF-kappa B activation at a level upstream of NF-kappa B-inducing kinase Antioxidants and Redox Signaling 2 2000 83 92
31. P. Teismann, K. Tieu, D.K. Choi, D.C. Wu, A. Naini, S. Hunot, M. Vila, V. Jackson-Lewis, and S. Przedborski Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration Proceedings of the National Academy of Sciences of the United States of America 100 2003 5473 5478
32. C.J. Van der Schyf, W.J. Geldenhuys, and M.B.H. Youdim Multifunctional drugs with different CNS targets for neuropsychiatric disorders Journal of Neurochemistry 99 2006 1033 1048
33. R. Vijitruth, M. Liu, D.Y. Choi, X.V. Nguyen, R.L. Hunter, and G. Bing Cyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson's disease Journal of Neuroinflammation 3 2006
34. V. Viswanath, Y.Q. Wu, R. Boonplueang, S. Chen, F.F. Stevenson, F. Yantiri, L.C. Yang, M.F. Beal, and J.K. Andersen Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1 2,3,6-tetrahydropyridine-induced Parkinson's disease Journal of Neuroscience 21 2001 9519 9528
35. H. Wilms, L. Zecca, P. Rosenstiel, J. Sievers, G. Deuschl, and R. Lucius Inflammation in Parkinson's diseases and other neurodegenerative diseases: cause and therapeutic implications Current Pharmaceutical Design 13 2007 1925 1928
36. X.-h. Yao, and X.-J. Li Protective effects and its mechanism of panaxatriol saponins isolated from Panax notoginseng on cerebral ischemia Zhongguo Zhongyao Zazhi 27 2002 371 373
37. M.B.H. Youdim, and J.J. Buccafusco Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders Trends in Pharmacological Sciences 26 2005 27 35
38. C. Zhou, Y. Huang, and S. Przedborski Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance Mitochondria and Oxidative Stress in Neurodegenerative Disorders 1147 2008 93 104